相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
Moussa Lingani et al.
MALARIA JOURNAL (2020)
Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal
Mamadou Alpha Diallo et al.
SCIENTIFIC REPORTS (2020)
Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated malaria and prevalence of Pfk13 and Pfmdr1 polymorphisms after a decade of using artemisinin-based combination therapy in mainland Tanzania
Deus S. Ishengoma et al.
MALARIA JOURNAL (2019)
Efficacy of artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria among children in Rwanda: an open-label, randomized controlled trial
Aline Uwimana et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2019)
Improving Methods for Analyzing Antimalarial Drug Efficacy Trials: Molecular Correction Based on Length-Polymorphic Markers msp-1, msp-2, and glurp
S. Jones et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
Therapeutic efficacy of artesunate-amodiaquine and artemether-lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015-2017
Benjamin Abuaku et al.
MALARIA JOURNAL (2019)
High therapeutic efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Somalia
Marian Warsame et al.
MALARIA JOURNAL (2019)
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children
Adoke Yeka et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambarene, Gabon: an open-label clinical trial
Bayode R. Adegbite et al.
MALARIA JOURNAL (2019)
Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials
Joy C. Ebenebe et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017
Elizabeth Davlantes et al.
MALARIA JOURNAL (2018)
Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
Francesco Grandesso et al.
MALARIA JOURNAL (2018)
Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial
Johanna M. Roth et al.
MALARIA JOURNAL (2018)
A randomized trial of dihydroartemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
Souleymane Dama et al.
MALARIA JOURNAL (2018)
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2017)
Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
Ngo Viet Thanh et al.
MALARIA JOURNAL (2017)
Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa
Feng Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia
Michael Teklemariam et al.
PLOS ONE (2017)
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
Bui Quang Phuc et al.
EMERGING INFECTIOUS DISEASES (2017)
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial
Adoke Yeka et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors
Aung Pyae Phyo et al.
CLINICAL INFECTIOUS DISEASES (2016)
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
D. Menard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
Kyaw M. Tun et al.
LANCET INFECTIOUS DISEASES (2015)
Malaria prevalence in Bata district, Equatorial Guinea: a cross-sectional study
Policarpo Ncogo et al.
MALARIA JOURNAL (2015)
Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study
Mathieu Ndounga et al.
MALARIA JOURNAL (2015)
Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia
Shannon Takala-Harrison et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P-falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
Meera Venkatesan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Efficacy and safety of artemether plus lumefantrine, artesunate plus sulphamethoxypyrazine-pyrimethamine and artesunate plus amodiaquine and sulphadoxine-pyrimethamine plus amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial
Djibrine Djalle et al.
MALARIA JOURNAL (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Artesunate/Amodiaquine Malaria Treatment for Equatorial Guinea (Central Africa)
Pilar Charle et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study:: Comparison of results based on genotyping of msp-1, msp-2, and glurp
A Cattamanchi et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2003)
分享论文
